These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27055429)
1. [Tissue heterogeneity analysis of CGG-repeat mutation in two fragile X affected male fetuses]. Huang W; Luo SY; Du Q; Yang P; Tan H; Wu LQ; Duan RH Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):287-9. PubMed ID: 27055429 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome]. Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory. Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462 [TBL] [Abstract][Full Text] [Related]
4. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening. Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238 [TBL] [Abstract][Full Text] [Related]
5. Maternal FMR1 premutation allele expansion and contraction in fraternal twins. Alfaro MP; Cohen M; Vnencak-Jones CL Am J Med Genet A; 2013 Oct; 161A(10):2620-5. PubMed ID: 23949867 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361 [TBL] [Abstract][Full Text] [Related]
8. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. de Graaff E; Willemsen R; Zhong N; de Die-Smulders CE; Brown WT; Freling G; Oostra B Am J Hum Genet; 1995 Sep; 57(3):609-18. PubMed ID: 7668289 [TBL] [Abstract][Full Text] [Related]
9. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses. Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172 [TBL] [Abstract][Full Text] [Related]
10. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays. Sølvsten C; Nielsen AL Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618 [TBL] [Abstract][Full Text] [Related]
11. Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male. Han XD; Powell BR; Phalin JL; Chehab FF Am J Med Genet A; 2006 Jul; 140(13):1463-71. PubMed ID: 16761284 [TBL] [Abstract][Full Text] [Related]
12. A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene. Wang H; Zhu X; Gui B; Cheung WC; Shi M; Yang Z; Kwok KY; Lim R; Pietilä S; Zhu Y; Choy KW J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566610 [TBL] [Abstract][Full Text] [Related]
14. Validation of Polymerase Chain Reaction-Based Assay to Detect Actual Number of CGG Repeats in FMR1 Gene in Indian Fragile X Syndrome Patients. Chowdhury MR; Chauhan S; Dabral A; Thelma BK; Gupta N; Kabra M J Child Neurol; 2017 Mar; 32(4):371-378. PubMed ID: 28193118 [TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability. Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283 [TBL] [Abstract][Full Text] [Related]
16. [Significance and case analysis of FMR1 mutation screening during early and middle pregnancy]. Cao Q; Mu W; Sun D; Zhu J; Ge J; Peng Y; Zhang J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 May; 38(5):450-453. PubMed ID: 33974253 [TBL] [Abstract][Full Text] [Related]
17. Detecting AGG Interruptions in Male and Female FMR1 Premutation Carriers by Single-Molecule Sequencing. Ardui S; Race V; Zablotskaya A; Hestand MS; Van Esch H; Devriendt K; Matthijs G; Vermeesch JR Hum Mutat; 2017 Mar; 38(3):324-331. PubMed ID: 27883256 [TBL] [Abstract][Full Text] [Related]
18. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation. Brouwer JR; Mientjes EJ; Bakker CE; Nieuwenhuizen IM; Severijnen LA; Van der Linde HC; Nelson DL; Oostra BA; Willemsen R Exp Cell Res; 2007 Jan; 313(2):244-53. PubMed ID: 17150213 [TBL] [Abstract][Full Text] [Related]
19. Use of methylation sensitive polymerase chain reaction for detection of fragile X full mutation & carrier state in males. Karunasagar A; Pandit L; Kumar S; Karunasagar I; Karunasagar I Indian J Med Res; 2005 Nov; 122(5):429-33. PubMed ID: 16456258 [TBL] [Abstract][Full Text] [Related]
20. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome. Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]